CONTACT US
MED TECH 
Medical technology is advancing at a spectacular rate. Knowledge is critical to holding a competitive edge. INOVIS brings over 30 years of expertise in primary intelligence and strategic analysis in Life Sciences and IT to help you build a leading Med Techmarket strategy
In 2023, the FDA approved more novel medical technologies than ever before – driven by advancements in AI, miniaturization, visualization, and neuromodulation. And, while MedTech growth rates fell a bit post-pandemic (according to an S&P Capital IQ report), they are picking up the pace once again.
With the swift evolution of MedTech, treatments in healthcare are showing tangible patient benefits faster – benefits like earlier detection and quicker healing, more precise surgical procedures, and even prevention of serious and chronic medical conditions.
Technological advancements and increasing acceptance of robotic surgeries, primarily in orthopedics and general surgery, by both surgeons and patients have fast-tracked development. And these innovative surgical robotics will rely on integration with advanced imaging systems and AI-driven diagnostics. Applications are already expanding to gynecology, neurosurgery, and dental surgeries.
As technology advances, the MedTech industry will run into challenges but also opportunities for delivering enhanced patient care, improved outcomes, and cost reduction. This evolution will reshape the healthcare landscape.
For MedTech companies, the rapid pace of innovation means that swift, exhaustive, reliable and proactive competitive intelligence will be essential to survival. The future won’t belong to the first-to-know, but the first-to anticipate.
Insights
Videos
Webinars
Events
Competitor Investigations
Tracking 
Medical Literature Intel
Security 
Consulting 
INO-house Tools ® 
Our Company
Our People
Our Clients
Careers
info@inovis.global
find us on LinkedIn
site map